pyrroles has been researched along with Diabetic Retinopathy in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Han, Y; Li, Y; Sun, P; Xu, N | 1 |
| Rolev, KD; Shu, XS; Ying, Y | 1 |
| Jain, M; Joharapurkar, A; Kshirsagar, S; Patel, MS; Patel, V; Savsani, H | 1 |
| He, M; Pan, H; Pu, M; Xiao, C | 1 |
| Bento, CF; Fernandes, R; Matafome, P; Pereira, P; Seiça, RM; Sena, CM | 1 |
| Abe, T; Kakehashi, A; Matsushita, M; Miyajima, K; Morinaga, H; Ohta, T; Sasase, T; Shinohara, M | 1 |
| Larijani, B; Mottaghi, S; Sharifi, AM | 1 |
| Bhansali, A; Gupta, A; Gupta, V; Thapar, S | 1 |
| Chakrabarti, S; Cukiernik, M; Downey, D; Evans, T; Hileeto, D; Mukherjee, S | 1 |
| Takagi, H; Watanabe, D | 1 |
| Kitano, S | 1 |
| Erkiliç, K; Koç, A; Mistik, S; Ozkiris, A | 1 |
3 review(s) available for pyrroles and Diabetic Retinopathy
| Article | Year |
|---|---|
Targeted pharmacotherapy against neurodegeneration and neuroinflammation in early diabetic retinopathy.
Topics: Anti-Inflammatory Agents; Antioxidants; Apoptosis; Astrocytes; beta Catenin; Diabetic Retinopathy; Ependymoglial Cells; Glutamic Acid; Glycogen Synthase Kinase 3 beta; Humans; Inflammation; Microglia; Mitochondria; Molecular Targeted Therapy; Neurodegenerative Diseases; Neuroglia; Neuroprotective Agents; Oxidative Stress; Pyrimidines; Pyrroles; Retinal Ganglion Cells; RNAi Therapeutics; tau Proteins | 2021 |
[Potential pharmacological treatments for diabetic retinopathy].
Topics: Aldehyde Reductase; Antioxidants; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Diabetic Retinopathy; Glycation End Products, Advanced; Growth Hormone; Guanidines; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazolidines; Indoles; Maleimides; Octreotide; Oxygen Inhalation Therapy; Platelet Aggregation Inhibitors; Protein Kinase C; Pyrroles; Thiamine; Vascular Endothelial Growth Factor A | 2005 |
[Medications for diabetic macular edema].
Topics: Acetazolamide; Diabetic Retinopathy; Diagnostic Techniques, Ophthalmological; Humans; Indoles; Injections, Intralesional; Macular Edema; Maleimides; Prognosis; Protein Kinase C; Protein Kinase C beta; Pyrroles; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2005 |
3 trial(s) available for pyrroles and Diabetic Retinopathy
| Article | Year |
|---|---|
Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema.
Topics: Administration, Oral; Atorvastatin; Chemotherapy, Adjuvant; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Exudates and Transudates; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Laser Coagulation; Lipoproteins, LDL; Macular Edema; Male; Middle Aged; Prospective Studies; Pyrroles; Triglycerides; Visual Acuity | 2004 |
Effect of atorvastatin on ocular blood flow velocities in patients with diabetic retinopathy.
Topics: Atorvastatin; Blood Flow Velocity; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Double-Blind Method; Eye; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Ophthalmic Artery; Pyrroles; Retinal Artery; Triglycerides | 2007 |
The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia.
Topics: Anticholesteremic Agents; Apolipoproteins B; Atorvastatin; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Dose-Response Relationship, Drug; Double-Blind Method; Fatty Acids, Nonesterified; Female; Heptanoic Acids; Humans; Hyperlipidemias; Lipoprotein Lipase; Lipoproteins; Male; Middle Aged; Placebos; Pyrroles; Time Factors; Triglycerides | 2001 |
7 other study(ies) available for pyrroles and Diabetic Retinopathy
| Article | Year |
|---|---|
Destruction of the blood-retina barrier in diabetic retinopathy depends on angiotensin-converting enzyme-mediated TGF-β1/Smad signaling pathway activation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cells, Cultured; Coculture Techniques; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Ependymoglial Cells; Fosinopril; Male; Peptidyl-Dipeptidase A; Pyrazoles; Pyrroles; Rats; Rats, Sprague-Dawley; Retina; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1 | 2020 |
Effect of dual PPAR-α/γ agonist saroglitazar on diabetic retinopathy and oxygen-induced retinopathy.
Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Chick Embryo; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Female; Hyperoxia; Intercellular Adhesion Molecule-1; Male; Neovascularization, Physiologic; Oxidative Stress; Phenylpropionates; PPAR alpha; PPAR gamma; Pyrroles; Rats, Sprague-Dawley; Receptors, Vascular Endothelial Growth Factor; Retina; Retinal Neovascularization; Retinal Vessels; Signal Transduction; Streptozocin; Transcription Factor RelA | 2021 |
Roles for redox signaling by NADPH oxidase in hyperglycemia-induced heme oxygenase-1 expression in the diabetic retina.
Topics: Acetophenones; Animals; Antioxidant Response Elements; Blotting, Western; Diabetic Retinopathy; Fluorescent Antibody Technique, Indirect; Glucose; Heme Oxygenase-1; Hyperglycemia; Imidazoles; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Organ Culture Techniques; Oxidation-Reduction; Oxidative Stress; Pyrroles; Reactive Oxygen Species; Retina; Signal Transduction | 2013 |
Atorvastatin-mediated protection of the retina in a model of diabetes with hyperlipidemia.
Topics: Animals; Antioxidants; Atorvastatin; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Diet, Atherogenic; Heptanoic Acids; Hyperlipidemias; Insulin Resistance; Lipid Metabolism; Male; Oxidative Stress; Proteasome Endopeptidase Complex; Pyrroles; Rats; Reactive Oxygen Species; Retina; Ubiquitin | 2014 |
Protein kinase C beta inhibitor prevents diabetic peripheral neuropathy, but not histopathological abnormalities of retina in Spontaneously Diabetic Torii rat.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Diabetic Retinopathy; Disease Models, Animal; Indans; Male; Neural Conduction; Protein Kinase C; Protein Kinase C beta; Pyrroles; Rats | 2009 |
Atorvastatin: an efficient step forward in mesenchymal stem cell therapy of diabetic retinopathy.
Topics: Animals; Atorvastatin; Diabetic Retinopathy; Gene Expression Regulation; Genetic Therapy; Heptanoic Acids; Humans; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Nitric Oxide; Nitric Oxide Synthase Type III; Pyrroles; Rats; Receptors, CXCR4; Vascular Endothelial Growth Factor A | 2013 |
Vascular endothelial growth factor in diabetes induced early retinal abnormalities.
Topics: Animals; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelin-1; Endothelin-3; Indoles; Male; MAP Kinase Signaling System; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrroles; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A | 2004 |